tirzepatide and liver enzymes Drug-induced injury secondary to Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

Significant alterations in estrogen levels can result in irregular periods or even missed periods

While directly measuring neuroprotection in living patients is technically unfeasible, alternative strategies, such as monitoring pro-inflammatory markers or neuroprotective cytokines in the plasma of patients receiving istradefylline, could offer valuable mechanistic insights and serve as surrogate indicators of therapeutic activity [485]

CGMP requirements are the same standards that pharmaceutical manufacturers, like Novo Nordisk, follow

It is now approved for several conditions: As a once-weekly injection in 0.5 mg, 1 mg, and 2 mg doses as an adjunct to diet and exercise for blood glucose management type 2 diabetes under the Ozempic label